| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 20,500 | 20,820 | 21.02. | |
| 20,740 | 20,780 | 20.02. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 22,560 | 200 | |||
| 22,500 | 1.000 | |||
| 21,860 | 100 | |||
| 21,700 | 2.500 | |||
| 21,460 | 50 | |||
| 21,200 | 2.700 | |||
| 20,840 | 16.485 | |||
| 20,740 | 227 | |||
| 20,720 | 4.222 | |||
| 20,660 | 403 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/gxi.htm [/URL] | ||||
| 403 | 20,500 | |||
| 948 | 20,440 | |||
| 227 | 20,420 | |||
| 6.000 | 20,400 | |||
| 3.274 | 20,380 | |||
| 500 | 20,340 | |||
| 16.485 | 20,260 | |||
| 2.500 | 20,100 | |||
| 200 | 20,020 | |||
| 45 | 20,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 30.582 | 0,912 | 27.887 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 20.02.2026 | 17:35:03 | 20,440 | 55.464 |
| 20.02.2026 | 17:27:58 | 20,600 | 44 |
| 20.02.2026 | 17:27:32 | 20,600 | 1.193 |
| 20.02.2026 | 17:27:30 | 20,640 | 2 |
| 20.02.2026 | 17:26:05 | 20,580 | 8 |
| 20.02.2026 | 17:23:27 | 20,600 | 176 |
| 20.02.2026 | 17:20:33 | 20,620 | 273 |
| 20.02.2026 | 17:20:00 | 20,640 | 174 |
| 20.02.2026 | 17:17:52 | 20,640 | 53 |
| 20.02.2026 | 17:14:30 | 20,680 | 3 |
| 20.02.2026 | 17:14:30 | 20,680 | 13 |
| 20.02.2026 | 17:14:30 | 20,660 | 194 |
| 20.02.2026 | 17:14:12 | 20,700 | 98 |
| 20.02.2026 | 17:12:00 | 20,720 | 24 |
| 20.02.2026 | 17:12:00 | 20,700 | 111 |
| 20.02.2026 | 17:01:40 | 20,740 | 224 |
| 20.02.2026 | 16:57:06 | 20,760 | 40 |
| 20.02.2026 | 16:56:39 | 20,800 | 12 |
| 20.02.2026 | 16:55:02 | 20,840 | 200 |
| 20.02.2026 | 16:54:27 | 20,820 | 12 |
| Tagesumsatz Xetra | -0,420 -2,01 % | 159.863 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:14 | Gerresheimer: Nach Kursdebakel - Jetzt das große Comeback? | RuMaS | |||
| Sa | Samstag Meldung zu GERRESHEIMER AG - Jetzt wird's ernst! | 37 | Maximilian Berger | ||
| Fr | Commodity rush at Almonty Industries, sell-off at SAP and Gerresheimer - where it is worth getting in now | 160 | The Market Herald Canada | ||
| GERRESHEIMER Aktie jetzt für 0€ handeln | |||||
| Fr | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 431 | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| Fr | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 423 | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Fr | Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy | GlobeNewswire (Europe) | Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the... ► Artikel lesen | |
| Breaking News: TeaRx erobert Großbritannien im Sturm?! | bullVestor | |||
| Sa | Aktien KW 8. News. Knorr Bremse. Jost. Norma Group. Ottobock. HHLA. STEYR Motors. Deutsche Rohstoff. Hapag Lloyd. technotrans | Nebenwerte Magazin | Aktien: Beim DAX konnte man letztendlich die 25.000er Marke behaupten. Wäre eigentlich eine schöne Ausgangsbasis für weitere Kursavancen. Aber die Unsicherheit über die Entwicklung im Nahen Osten mit... ► Artikel lesen | |
| Do | 20/20 Biolabs Inc.: 20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth | GlobeNewswire (Europe) | Company Ready to Scale Growth through OneTest AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market... ► Artikel lesen | |
| Fr | DiagnosTear Technologies Inc.: DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of rapid point-of-care diagnostics... ► Artikel lesen |